- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- 2025-04-25, 18:22:29
- Local Time:
- 2025-05-09, 20:34:52
- Last Active:
- 2025-04-25, 21:35:49
Signature:
Objective To estimate the cost-effectiveness of first line tyrosine kinase inhibitors (TKI), afatinib and osimertinib, for the treatment of epidermal